PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Service de Pharmacologie Médicale, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, 37 allées Jules Guesde, Toulouse, 31000, France.\', \'Centre d\'Investigation Clinique 1436, axe pharmacoépidémiologie, Centre Hospitalier Universitaire de Toulouse-Purpan, place du Dr Baylac, TSA40031, Toulouse Cedex 9, 31059, France.\', \'Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse-Purpan, place du Dr Baylac, Toulouse Cedex 9, TSA40031, 31059, France.\', \'UMR INSERM/CNRS 1043, Centre de Physiopathologie Toulouse Purpan, 330 avenue de Grande-Bretagne, Toulouse cedex 9, 31059, France.\', \'Service des Urgences, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.\', \'Service de Médecine Interne, salle Le Tallec, Centre Hospitalier Universitaire de Toulouse-Purpan, place du Dr Baylac, TSA40031, Toulouse Cedex 9, 31059, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/fcp.12613
?:doi
?:hasPublicationType
?:journal
  • Fundamental & clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33111329
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33111329>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33111329>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all